Alan S. Cross, MD; Steven M. Opal, MD
Grant Support: By National Institutes of Health grant RO1 AI42181-01.
Potential Financial Conflicts of Interest:Honoraria: S.M. Opal (Wyeth Research, Lilly Research Laboratories, Aventis Behring, ICOS Corp., Merck & Co.); Grants received: S.M. Opal (Wyeth Research, Chiron Corp.).
Requests for Single Reprints: Alan S. Cross, MD, Department of Medicine, Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, HSF 480, Baltimore, MD 21201; e-mail, email@example.com.
Current Author Addresses: Dr. Cross: Department of Medicine, Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, HSF 480, Baltimore, MD 21201.
Dr. Opal: Division of Infectious Diseases, Memorial Hospital of Rhode Island, 111 Brewster Street, Pawtucket, RI 02860.
Cross AS, Opal SM. A New Paradigm for the Treatment of Sepsis: Is It Time To Consider Combination Therapy?. Ann Intern Med. 2003;138:502–505. doi: 10.7326/0003-4819-138-6-200303180-00016
Download citation file:
Published: Ann Intern Med. 2003;138(6):502-505.
Multi-Organ Failure and Sepsis, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use